Multiple glass vials sourcing to secure your parenteral drug supply

Explore the innovative world of molded glass vials

Presented by:

  • Free

Why attend?

In 2021, worldwide capacities of tubular glass vials have been under stress to cover the global market need and this trend is expected to continue.

To face this challenge, pharma, biopharma and veterinary customers may validate multiple sources of glass vials (tubular and molded) to alleviate the strain currently placed on their supply chain. Whether you are developing a COVID-19 vaccine or new treatments, or if you are a CMO filling parenteral drugs, we understand that the integration of a new container solution in a manufacturing process designed for tubular glass vials can be a challenge from both a regulatory and a manufacturing point of view. Alongside regulatory hurdles, some adaptations to your manufacturing process may be required to address the differences between tubular and molded glass vials in terms of machinability. However, the benefits far outweigh the challenge of a lack of vials for your drug, which impacts time to market and brand confidence. At SGD Pharma, we want to share our expertise and demonstrate the support available to help you avoid supply chain bottlenecks. We have analyzed the current challenges and have the experience to support you to ease the switch to or integration of molded glass vials in your SOP.

Please join Dr. Jingwei Zhang and Carole Grassi Mircich from SGD Pharma to learn about the characteristics of molded and tubular glass and what considerations should be made when evaluating a new glass packaging solution for parenteral drugs. This webinar will then focus on how advances in Type I molded glass vials can help you to overcome some of the challenges of aseptic filling: Tim Wenzel from GILYOS will present his cutting-edge research on lyophilization and the advantages of innovative vial design on heat transfer, and Markus Heinz from Syntegon will present his technical study assessing the processability of molded glass vs tubular glass in the depyrogenation tunnel.

If you work in a pharma or veterinary drug manufacturing lab or a CMO and want to learn more about how to mitigate the risk of supply chain disruptions for glass packaging, please register for our webinar.

Key Learning Objectives

  • Understand the position of molded and tubular glass in the parenteral packaging market and know which glass types are suitable for parenteral drugs.
  • Learn the key benefits of introducing molded glass vials into your portfolio.
  • Understand the latest developments in molded glass vial design and aseptic processing.
  • Learn how to incorporate molded glass as an alternative/additional packaging solution.

Target Audience

  • Head/vice president of innovation,
  • Head of primary packaging development,
  • Manager of R&D for primary packaging,
  • Packaging development manager,
  • Vice president of operations,
  • Scientific in charge of new drugs developments,
  • Head/Director/Vice president of operations,
  • Head/Director/Vice president of Manufacturing operations,
  • Process/Product Development Manager,
  • Head/Director/Vice president of procurement,
  • Sourcing Manager,
  • Purchasing Manager,
  • Plant manager,
  • Project Manager,
  • Project manager of new production facilities or production capacity extension,
  • Business Development manager,
  • Aseptic area manager,
  • Research & development engineer,
  • Quality Assurance Engineer,
  • Product manager,
  • Consultant on transition from clinical phases to industrialization phases of new drugs

Speakers

Select a speaker to learn more

Matthias Angelmaier
Global Product Manager, Syntegon

Matthias Angelmaier has a bachelor’s degree in industrial and mechanical engineering as well as a master’s degree in business development. He joined Syntegon Technology GmbH (former Bosch Packaging Technology) in 2009.

During his first 3 years, he was a project manager for handling complex customer projects.

Since 2012, he is the globally responsible product manager for barrier systems, isolator and process technology. His expertise includes process engineering, sterilization, bio-decontamination, aseptic and high-potent Isolator applications, glove testing systems as well as topics related to advanced aseptic processing. He is a frequent speaker on international symposia and conferences including organizations like ISPE and PDA.

Next speaker
Tim Wenzel
Scientist II

Tim Wenzel is a licensed pharmacist in Germany. After graduation from the University of Münster, he pursued his PhD in Pharmaceutical Technology at the University of Erlangen in the Freeze Drying Focus Group led by Henning Gieseler. His research encompassed projects in the fields of controlled ice nucleation, vial heat transfer characteristics, novel packaging materials, miniaturized freeze drying equipment and X-ray microtomography-based product inspection. In 2020, Tim transitioned into the company GILYOS, a contract service provider in the field of freeze drying focusing on formulation and process development.

Next speaker
Carole Grassi Mircich
Chief Innovation & Development Officer

Carole Grassi Mircich has worked as Chief Innovation & Development Officer at SGD Pharma since May 2019. She is currently in charge of innovation and development as well as strategic marketing, product management, market intelligence, and communication. From May 2017 to June 2019, Carole was Vice President of Marketing & Communication for the group, where she created a new marketing team. Before joining SGD Pharma, Carole spent more than ten years at Rexam Plc, which later became Albéa Packaging. Carole started as Strategy & Business Developer in the UK for the Plastic Division, where she worked with the respective General Managers of the Business Units (Pharma, Cosmetics and Food). Carole then became Cosmetics Category Manager in the Beauty BU and then Marketing Director of the Dispensing Systems BU where she was responsible for market analysis, innovation and product development.

Next speaker
Jingwei Zhang
R&D Director

Jingwei ZHANG is currently R&D director of SGD Pharma, based in France.
Previously to this position, he worked for Saint-Gobain for 24 years, as strategic projects manager and R&D portfolio manager. He has a large experience in glass packaging, ranging from products and process development to quality inspection. He is inventor of more than 70 international patents.
Jingwei ZHANG graduated from Harbin Institute of Technology in China, and received his PhD in France.

Next speaker

Contact us

If you want to become a sponsor, speak at an event or become a partner, leave a message at the "Partner with us" page and we will contact you as soon as possible.